← Leaderboards
Svenja Illien-Junger
Icahn School Of Medicine At Mount Sinai
$1,687,589
Attributed
$1,800,073
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $599.8K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,201,339 · 4
By mechanism
R01$1,562,670 · 1
R21$638,669 · 3
Top collaborators
- Samantha M. Yeligar1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- James C Iatridis$19,034,759
- Roger J. Hajjar$21,947,839
- Lahouaria Hadri$8,134,686
- Marta Filizola$11,220,258
- Grace Ellen Mosley$150,060
Others in their field
Other Emerging Leaders on “United States”
- Leonard Freedman · Leidos Biomedical Research, Inc.$818,172,357
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$284,203,793
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
United StatesNucleus PulposusTissuesCellularityInnovationPathway InteractionsPainSignal TransductionBack PainCellsIntervertebral Disc StructureIntervertebral Disk DegenerationPlayIn VivoMinimally InvasiveIn VitroKnock-OutDegenerative PolyarthritisKnockout MiceCell ProliferationChronicApoptosisInflammatoryGenes
Grant awards (9)
Targeting PHLPP to treat interval disc degeneration using surgical and drug delivery methods$374,860
R01 · FY2025 · AR · contact PI
Mechanisms of and treatments for alcohol-induced disc degeneration$224,969
R21 · FY2025 · AA · contact PI
Targeting PHLPP to treat interval disc degeneration using surgical and drug delivery methods$382,876
R01 · FY2024 · AR · contact PI
Targeting PHLPP to treat interval disc degeneration using surgical and drug delivery methods$396,162
R01 · FY2023 · AR · contact PI
Targeting PHLPP to treat interval disc degeneration using surgical and drug delivery methods$408,772
R01 · FY2022 · AR · contact PI
Targeting PHLPP1 to Inhibit Progression of Intervertebral Disc Degeneration$113,121
R21 · FY2019 · AR · contact PI
Targeting PHLPP1 to Inhibit Progression of Intervertebral Disc Degeneration$53,964
R21 · FY2019 · AR · contact PI
ConProject-001$12,434
R21 · FY2019 · AR · contact PI
Targeting PHLPP1 to Inhibit Progression of Intervertebral Disc Degeneration$234,181
R21 · FY2018 · AR · contact PI